Table 1.
Baseline characteristics.
|
Study |
Patient characteristics |
Procedure information |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Study, date, (total patients no.) | Study design | Risk of bias | Patients who underwent neuro-interventional procedures with Angio-Seal device | Female gender (%) | Mean age | Mean BMI (kg/m²) | Stroke or SAH (%) | HTN (%) | DM (%) | Cardiac morbidities (%) | Dyslipidemia (%) | Sheath size -Fr- (mean) | No. of patients on tPA (%) | No. of patients on Anticoagulant (%) | No. of patients on Antiplatelet (%) |
| Pierot et al.6 | P | Low | 119 | 53 | 51.60 | 4 pt >30 | NR | 19.3 | 9.2 | NR | NR | 6.27 | NR | 67.2 | NR |
| Geyik et al.15 | R | Mod | 640 | 46.4 | 54.50 | NR | NR | NR | NR | NR | NR | 6.42 | NR | 21.25 | 48.75 |
| Wong et al.12 (153) | P | Low | 90 | 43.8 | 56.10 | NR | NR | NR | NR | NR | NR | 6 or 8 | NR | NR | NR |
| Shah et al.8 (472) | R | Mod | 443a | 50 | 70.00 | NR | NR | NR | NR | NR | NR | 8.05 | 55.1 | 12.7 | 2.1 (DAPT) |
| Shah et al.10 (234) | R | High | 98b | 61.5 | 52.50 | NR | NR | NR | NR | NR | 10.25 | 8 | NR | 40.6 | 17.1 |
| Sato et al.16 | P | Low | 119 | 47.06 | 62.10 | 34.00 | NR | 52.1 | 13.4 | NR | 30.25 | 7.36 | 2.5 | 7.5 | 89.1 |
| Aida et al.11 (141) | R | Low | 141 | 54.6 | 63.07 | 22.99 | NR | 64.5 | 18.4 | NR | 31.2 | 6.3 | NR | NR | 77.3 |
| Janssen et al.6 (72) | R | High | 72 | 52.8 | 70.60 | NR | 100 | 86.1 | 29.2 | 48.6 | 61.1 | 9 | 63.9 | 20.8 | 33.3 |
| Wareham et al.14 (145)] | R | Mod | 145 | 51 | 69.10 | NR | 100 | 33.1 | 7.6 | 25.5 | NR | 8 | 48.3 | 11.7 | 4.8 |
| Addepalli et al.13 (459) | R | Low | 197 | 68.5 | 53.50 | 29.95 | 100 | 62.9 | 16.75 | NR | NR | NR | NR | 60.9 | NR |
| Ishida et al.17 (60) | R | Mod | 60 | 13.3 | 71.10 | NR | NR | 81.7 | 41.7 | NR | 88.3 | NR | NR | 100 | 100 |
| Ozono et al.9 (116) | R | Mod | 126 | 46.8 | 68 | 23.35 | 19 | 65.9 | 24.6 | 15.1 | 44.4 | NR | NR | 100 | NR |
HTN: Hypertension, DM: Diabetes Mellitus, P: Prospective, R: Retrospective, NR: Not reported, DAPT: Dual Antiplatelet Therapy, Pt: Patient, Mod: Moderate.
aThe baseline characteristics of the Angio-Seal group were mixed with the data of patients with other vascular closure devices but the outcomes of each group were reported clearly.
bThe baseline characteristics of the patients who underwent interventional procedures were mixed with the ones who underwent diagnostic procedures but the outcomes of each group were reported clearly.